Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-02-20
2007-02-20
Woitach, Joseph (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093100, C536S023100, C530S350000
Reexamination Certificate
active
10257384
ABSTRACT:
This invention relates to an agent for producing a pharmaceutical drug for postoperative use after removal of bone tumors produced from a nucleic acid by linking a known sequence for promoting bone growth and a known proteinase inhibitor by a variable spacer molecule. This linkage results in a novel bifunctional active ingredient combining both properties in a biological molecule. This invention is used in the medical field, in particular in the specialty field of orthopedics.
REFERENCES:
patent: 5935935 (1999-08-01), Connelly et al.
patent: 5942496 (1999-08-01), Bonadio et al.
patent: 5962427 (1999-10-01), Goldstein et al.
patent: 0 504 938 (1992-09-01), None
patent: 0 704 532 (1996-04-01), None
patent: WO 91/19510 (1991-12-01), None
patent: WO 98/51788 (1998-11-01), None
patent: WO 98/55137 (1998-12-01), None
patent: WO 01/078756 (2001-10-01), None
Deonarain (1998) Exp. Opin. Ther. Pat., 8(1): 53-69.
Gorecki (2001) Exp. Opin. Emerging Drugs, 6(2): 187-98.
Verma, et al. (1997) Nature, 389: 239-42.
Eck, et al. (1996) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., McGraw-Hill, New York, NY., pp. 77-101.
Neaud, et al. (2000) J. Biol. Chem., 275(45): 35565-69.
Zhang, et al. (2003) Oncogene, 22: 974-82.
Gafni, et al. (2004) Molecular Therapy, 9(4): 587-95.
Hughes (2004) J. Surg. Oncol., 85: 28-35.
Taguchi S et al: Microbial secretion of biologically active human transforming growth factor alpha fused to the Streptomyces protease inhibitor; vol. 159, No. 2, (Jul. 4, 1995), pp. 239-243. XP002173729 figure 2C.
Kolkhorst V et al: Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile; J Cancer Res Clin Oncol., vol. 124, No. 11, 1998, pp. 598-606, XP002179730.
Maubach Gunter
Wiederanders Bernd
Depuy Biotech Jena GmbH
Hall, Vande Sande & Pequignot LLP
Kelly Robert M.
Natzmer Joyce Von
Woitach Joseph
LandOfFree
Nucleic acids encoding chimeric proteins comprising BMP-2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids encoding chimeric proteins comprising BMP-2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding chimeric proteins comprising BMP-2... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3812586